Harvest Fund Management Co. Ltd Purchases New Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Harvest Fund Management Co. Ltd bought a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 12,947 shares of the company’s stock, valued at approximately $424,000.

Several other large investors have also added to or reduced their stakes in ARKG. Operose Advisors LLC bought a new stake in ARK Genomic Revolution ETF during the third quarter worth $25,000. Stephens Consulting LLC bought a new position in shares of ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $28,000. Allworth Financial LP lifted its position in shares of ARK Genomic Revolution ETF by 65.3% during the 3rd quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock valued at $40,000 after buying an additional 563 shares during the last quarter. Naples Money Management LLC bought a new stake in ARK Genomic Revolution ETF in the 4th quarter valued at about $63,000. Finally, BKM Wealth Management LLC bought a new position in ARK Genomic Revolution ETF in the 4th quarter worth approximately $78,000.

ARK Genomic Revolution ETF Price Performance

Shares of BATS:ARKG traded down $0.30 during trading on Wednesday, hitting $23.68. 2,538,687 shares of the company were exchanged. The firm’s 50-day moving average is $28.54 and its 200 day moving average is $28.43.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.